Research Use Only Disclaimer
CJC-1295 No DAC is sold strictly for laboratory, academic and institutional research. It is not for human or animal consumption, injection, or any therapeutic, diagnostic or veterinary use. PCH Peptides does not provide dosage, administration or usage guidance.
What Is CJC-1295 No DAC?
CJC-1295 No DAC is a modified version of the first 29 amino acids of growth-hormone-releasing hormone (GHRH). Four substitutions (D-Ala2, Gln8, Ala15 and Leu27) make it more resistant to enzymatic breakdown than native GRF (1-29).
“No DAC” means it has no drug affinity complex, the lysine-linked group that lets CJC-1295 with DAC bind albumin. Researchers choose the No DAC form when a study calls for a shorter-acting GHRH analogue for GHRH-receptor binding and signalling models.
For additional background on this class of compounds, explore the list of research peptides, which covers commonly studied peptides and their laboratory research applications.
CJC-1295 No DAC 10mg Specifications
| Property | Value |
| Also known as | Modified GRF (1-29), Mod GRF 1-29 |
| Length | 29 amino acids, C-terminal amide |
| Molecular formula | C152H252N44O42 |
| Molecular weight | 3367.9 g/mol |
| Amount per vial | 10mg |
| Form | Lyophilized powder |
| Purity (reported batch) | 99.64% (HPLC; confirm against current batch COA) |
Certificate of Analysis
The reported batch HPLC purity is 99.64% for the 10mg configuration. The product page provides access to its Certificate of Analysis and endotoxin report. Researchers should check the current batch documentation to confirm the applicable purity result and batch identity.
Additional testing records and available analytical documentation can be found in the PCH Peptides COA Library.
Batch-specific certificates help laboratories review material identity, purity and analytical findings before conducting research.
Storage and Handling
Keep the vial sealed until it is needed in an authorized laboratory workflow. Store it cold, dry and away from light, following the temperature on the label and any batch-specific documentation.
Reconstitution Solution is available separately for appropriate laboratory workflows.
Researchers can also review the educational guide on how peptide reconstitution works for information about lyophilized materials, general handling considerations and laboratory preparation principles.
Related Research Materials
CJC-1295 No DAC is studied in laboratory models involving GHRH-receptor activity and peptide signalling. Researchers investigating related pathways may also examine other peptide analogues and receptor-binding compounds.
- Ipamorelin – A synthetic pentapeptide investigated in ghrelin-receptor binding and peptide signalling research.
- CJC-1295 No DAC / Ipamorelin Blend – A combined research material containing CJC-1295 No DAC and Ipamorelin for controlled, non-clinical laboratory studies.
- Tesamorelin – A stabilized synthetic GHRH analogue studied in receptor interaction and signalling pathway models.
Browse the full range of research peptides available through PCH Peptides.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC carries a drug affinity complex that binds albumin and extends its half-life. The No DAC version, Mod GRF 1-29, lacks this group and is shorter-acting in research models.
Is CJC-1295 No DAC the same as Mod GRF 1-29?
Yes. CJC-1295 No DAC and Modified GRF (1-29) are two names commonly used for the same tetra-substituted 29-amino-acid GHRH analogue.
What is CJC-1295 No DAC studied for?
CJC-1295 No DAC is investigated in laboratory research involving GHRH-receptor binding, peptide stability, molecular characterization and related signalling pathways. It may also be examined alongside other research peptides in comparative receptor-interaction models.
What purity is your CJC-1295 No DAC?
The reported batch tested at 99.64% purity by HPLC. Researchers should confirm this result against the current batch Certificate of Analysis available through the product page or COA Library.
What size is the CJC-1295 No DAC vial?
Each vial contains 10mg of lyophilized CJC-1295 No DAC, supplied as a research material for laboratory, academic and institutional study.
How should CJC-1295 No DAC be stored?
CJC-1295 No DAC should be kept in its sealed container, protected from moisture, excessive heat and direct light. Follow the product label and batch-specific storage recommendations to maintain material integrity.
Is CJC-1295 No DAC intended for human use?
No. CJC-1295 No DAC is supplied strictly for laboratory research and is not intended for human or animal consumption, injection, therapeutic applications or veterinary use.
For more information about research material classifications, read the Research Use Only Peptides Guide.
Do you provide dosage instructions for CJC-1295 No DAC?
No. PCH Peptides does not provide dosage, administration or usage protocols. CJC-1295 No DAC is supplied for qualified research use only.
